Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Benzbromarone in CKD with Hyperuricemia
NCT02944214Unknown
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Oct 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in chronic kidney disease (CKD) and hyperuricemia comparing Febuxostat with Benzbromarone (2 arms). Primary endpoints: Serum Creatinine at 12 months and Estimated Glomerular Filtration Rate at 12 months. Status: unknown.
02
Drugs
febuxostatbenzbromarone
03
Conditions
chronic kidney disease (CKD)hyperuricemia
Beyond the preview
Go deeper on NCT02944214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944214.